Corporate defendants face a mounting threat of expanded state court jurisdiction. On April 25, 2017, the US Supreme Court is scheduled to hear oral argument on a major personal jurisdiction decision, known as the "Plavix" decision, that will greatly impact product liability and other high-stakes litigation throughout the country.
President Trump's nomination of Neil Gorsuch on January 31, 2017, to fill the seat left by Justice Scalia's passing is a crucial one, given the far-reaching implications the "Plavix" decision will have on large national corporations. Bristol-Myers Squibb Company v. Super. Ct. of San Francisco Cnty. (Anderson), 1 Cal. 5th 783 (Aug. 29, 2016). Judge Gorsuch's confirmation hearing is currently scheduled for March 20, 2017. An analysis of some of Justice Gorsuch's key opinions during his tenure on the Tenth Circuit sheds light onto his views of jurisdiction over corporate defendants.
Our webinar will discuss a few of Justice Gorsuch's Tenth Circuit opinions, and the insights those rulings provide as to how Justice Gorsuch might vote on "Plavix," should he be confirmed prior to April 25.